SCHEMBL7143630

SCHEMBL7143630

CCOC(=O)CCN1CCC(CC2COc3c(C(=O)O)cc(Cl)c(N)c3O2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 12/20 0.48
HTR2C P28335 5/20 0.48
HTR3A P46098 5/20 0.48
HTR3E A5X5Y0 2/20 0.48
HTR3B O95264 2/20 0.48
HTR3D Q70Z44 2/20 0.48
HTR3C Q8WXA8 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
ADRA1A P35348 5/20 0.47
ADRA2C P18825 4/20 0.47
ADRA2A P08913 3/20 0.47
HTR2A P28223 3/20 0.47
HTR1D P28221 3/20 0.47
HTR2B P41595 3/20 0.47
LMNA P02545 1/20 0.47
THRB P10828 1/20 0.47
HRH1 P35367 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7404756 0.87 HTR4 (0.58) HTR4HTR2CHTR3AHTR3EHTR3B
Hydrochloric Acid SCHEMBL7399150 0.86 HTR2C (0.59) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL6776570 0.84 HTR4 (0.45) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL7398143 0.81 HTR4 (0.47) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL7400000 0.80 HTR4 (0.58) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL7396269 0.79 HTR4 (0.46) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL7398605 0.78 HTR4 (0.42) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL8696154 0.78 HTR4 (0.48) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL6783415 0.77 HTR4 (0.78) HTR4HTR2CHTR3AHTR3EHTR3B
SCHEMBL8323554 0.77 HTR4 (0.37) HTR4HTR2CHTR3AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0667867-A1 PIPERIDINE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-08-23 EP claimed
WO-1994010174-A1 PIPERIDINE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-05-11 WO claimed
US-20030153573-A1 Novel N-substituted 4-((-4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties BOSMANS JEAN-PAUL RENE MARIE (BE) 2003-08-14 US disclosed
EP-0885190-B1 N-SUBSTITUTED 4-((4'-AMINOBENZOYL)-OXYMETHYL)-PIPERIDINES HAVING GASTRIC PROKINETIC PROPERTIES JANSSEN PHARMACEUTICA NV (BE) 2003-05-07 EP disclosed
EP-0880500-B1 ESTERS OF 3-HYDROXY-PIPERIDINEMETHANOL DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2002-07-31 EP disclosed
US-6096761-A REACTING A N-SUBSTITUTED 4-METHANOL-3-HYDROXY OR ALKOXY-PIPERIDINE INTERMEDIATE WITH A CARBOXYLIC ACID DERIVATIVES; ADMINISTERING TO AN ANIMAL SUFFERING WITH A CONDITION RELATED TO HAMPERED OR IMPAIRED GASTRIC EMPTYING JANSSEN PHARMACEUTICA N.V. (BE) 2000-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153573-A1 Novel N-substituted 4-((-4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties GIPR, CRHR1, GRPR HTR4 65/4885HTR2C 76/4885HTR3A 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.